The main task of the Board of Directors, under the leadership of the Chairman, is to determine the company’s general policy and to supervise its activities.
Aly Talen, RN - Director
Aly has a degree in general and psychiatric nursing and extensive cathlab experience. She founded the CRO “Talen Clinical Trial Management” in 2001 which later was acquired by genae in 2005. Aly’s rich experience and network in the clinical field make her a credible and reliable partner in discussions with key opinion leaders and the medical industries. She is a talented communicator with a strong clinical research background.
Bart Segers - Chairman
Bart holds an engineering degree and previously gave leadership to the EU Sales & Marketing team as Managing Director at the Spectranetics Corporation. In 2005, he co-founded genae, a global, mid-sized CRO and services provider for the medical industries with focus on medical devices. He currently rolls-out an M&A strategy for the genae group to expand global operations.
Christoph Waer - Director
Christoph is a Senior Investment Manager at Korys, focusing on the fund's investments in the life science sector. In this capacity, he currently also represents Korys on the board of Agendia, Bluebee and MyCartis. Prior to joining Korys, Christoph worked in the Corporate Finance department of Fortis Bank in France (now BNP Paribas) and at iPierian, a San Francisco biotech start-up company.
Thomas De Kempeneer - Director
Thomas is a Senior Investment Manager at Korys with a focus on direct investments. Previously, Thomas was active at BNP Paribas Fortis until 2008 and at KBC Private Equity until 2012. As a private equity professional, he focuses on growth capital and buy-out transactions in the mid-market both in Belgium and surrounding countries. He has an extensive experience as a board member and currently holds and has held several board mandates across multiple sectors in different geographies. Thomas holds a Master in Financial Management from the Vlerick Management School and a Master in Applied Economics from the University of Ghent.
Youri Steverlynck, LLM - Non-executive Director
Youri Steverlynck is a partner at the law firm Lexeco and a curator at the Commercial Court of Antwerp. He gained a degree in law from the KUL in 1996 and was appointed in 1997 to the Bar of Antwerp. From 2002 to 2008 he held various management positions in companies in Belgium and abroad, first at the corporate affairs department, later in the marketing department and finally as CEO. In 2009 he became a full-time partner at Lexeco. Youri focuses on corporate law. He specializes in restructuring and insolvency law and has extensive experience in corporate law, mergers and acquisitions, shareholder disputes, director liability and contracts. He has particular expertise in finance & securities. In recent years, Youri frequently served as liquidator in complex dissolutions of companies. He enjoys a broad international experience in commercial negotiations, sector regulation and in dealing with public authorities. One of Youri’s key differentiatiors, in supporting an entrepreneur as a lawyer, is actually thinking like an entrepreneur.
Ingrid Maes - Non-executive Director
Ingrid is co-Founder and Managing Director of Inovigate. She has more than 30 years of experience in the pharmaceutical, medical device and life science sector, and 15 years’ experience in international leadership roles at Alfa Laval, Siemens and PwC. She is an expert in business planning and strategy formulation, in R&D and market access, manufacturing and regulatory compliance and bridges the scientific / technology world with the strategy and finance aspects of the business. Ingrid is a member of various think tanks and advised FDA and EMA on adoption of innovative technologies. She gained a Master in Engineering Sciences - Chemistry & Biotechnology, Medicinal chemistry from the University of Brussels.
Want to hear more about our services or how we can support your clinical trial? Feel free to contact us with any questions you may have.Contact us